|
| |
celgene email exchange Pages on BioPortfolio:
Celgene Needs a Phase III Trial
Celgene will conduct an additional clinical trial in multiple myeloma. .... Changes in rates of currency exchange may have an adverse effect on the value,
...
http://www.bioportfolio.com/news/btech_030802_2.htm...
|
Biotechnology News regulatory Search
London Stock Exchange: Oct 6 2008 12:35PM .... Celgene International S rl (CELG) announced that its oral cancer drug REVLIMID (lenalidomide) has received ...
http://www.bioportfolio.co.uk/regulatory-news.htm...
|
BioTech Stock Report: Celgene
Celgene plans to report its earnings for the fourth quarter 2003 and ... Changes in rates of currency exchange may have an adverse effect on the value, ...
http://www.bioportfolio.com/news/biotechsage_39.htm...
|
BioPortfolio Biotechnology BioNews : live article
REVLIMID(R) and RevAssist(R) are registered trademarks of Celgene Corporation. ... Securities and Exchange Commission such as our 10K, 10Q and 8K reports. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - Celgene Corporation - Profile
A novel mixed-mode reversed-phase and cation-exchange high-performance...31st May, 2008. Analytical Research and Development, Celgene Corporation, Summit, ...
http://www.bioportfolio.com/biocorporate/466-Celgene+Corpora...
|
Biotechnology News investment enersi. bhi. zack. baker. fsy. 2197 ...
Industrial Biotechnology Corporation and the Plastics Exchange Announce ... Highlights: Genentech, ImClone Systems, Bristol-Myers Squibb and Celgene ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioTech Sage Report - ReCap on BioGen, Celgene, ICOS, Genzyme, Imclone
Second, Celgene announced that the company would acquire Anthrogenesis for $45 .... Changes in rates of currency exchange may have an adverse effect on the ...
http://www.bioportfolio.com/news/biotechsage_1.htm...
|
Biotechnology News livesciencecom. men. brain. women. wire. synaps ...
Securities and Exchange Commission of, and requested an investigation into, ... Celgene Corporation to Present at the Bank of America 38th Annual Investment ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Revmid Receives Another Fast Track Designation
April 16, 2003, Celgene’s (NYSE: CELG) Revmid (CC-5013) received fast track ... Changes in rates of currency exchange may have an adverse effect on the ...
http://www.bioportfolio.com/news/biotracker_100.htm...
|
Biotechnology News aastrom. nasdaqcmastm. iss. supermajor. vote ...
(NASDAQ: CRTX - News) announced today that the Securities and Exchange ... Celgene shares gain ground with the broader market, on boost from Cowen's Vidaza
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Results from other life science and pharmaceutical sites:
Celgene Provides Update On Clinical Pipeline
The Phase I/II clinical study, conducted jointly by Celgene and the NCI, .... with the Securities and Exchange Commission such as 10K, 10Q and 8K reports. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Acceleron Pharma Announces Global Collaboration with Celgene on ...
20 Feb 2008 ... Under the terms of the agreement, Celgene and Acceleron will jointly ... described in Celgene’s filings with the Securities and Exchange ...
http://www.biospace.com/news_story.aspx?NewsEntityId=86623...
|
Celgene Names David W. Gryska Chief Financial Officer
He will report to Sol J. Barer, Ph.D, Chief Executive Officer of Celgene ... the Securities and Exchange Commission such as our 10K, 10Q and 8K reports. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Celgene Pulls Out of GPC Biotech AG Prostate Cancer Drug Deal ...
7 Aug 2008 ... Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today reported that the Company has received notice from Celgene Corporation of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=106104...
|
Summary of CELGENE CORP /DE/ - Yahoo! Finance
Celgene Corporation (the "Company") entered into an Agreement and Plan of ... the Exchange Ratio will be .8370 and if the Measurement Price is greater than
...
http://biz.yahoo.com/e/071119/celg8-k.html...
|
Celgene's Amrubicin(R) Receives FDA Orphan Drug Designation for ...
25 Mar 2008 ... Celgene Corporation, headquartered in Summit, New Jersey, is an integrated ... and Exchange Commission such as our 10K, 10Q and 8K reports. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=90345...
|
Celgene Corporation Announces Two-For-One Stock Split
Reporting of the Celgene share price on a split-adjusted basis is expected ... the Securities and Exchange Commission such as our 10K, 10Q and 8K reports. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Celgene Corporation to Present at the UBS 2008 Global Life ...
SUMMIT, NJ--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG - News) ... with the Securities and Exchange Commission such as 10K, 10Q and 8K reports. ...
http://biz.yahoo.com/bw/080919/20080919005835.html?.v=1...
|
Array BioPharma, Inc. and Celgene in $40 Million Cancer ...
24 Sep 2007 ... Under the agreement, Celgene will make an upfront payment of $40 million to ... filed by Array with the Securities and Exchange Commission. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=70738...
|
Press Releases: Pharmacopeia
Pharmacopeia - Celgene Collaboration Results in Nomination Of a Novel Drug Candidate ... Pharmacopeia has filed with the Securities and Exchange Commission
, ...
http://www.pharmacopeia.com/wt/redirect/PS873266...
|
|
